RxSight Q3 2021 revenue $5.8M (+39% YoY); net loss $12.7M; FY revenue guidance $21.0-$21.4M

RxSight, Inc.

2021-Q3 EPS reported -$3.66 revenue$14,167,000

Q3 revenue $5.8M, up 39% YoY and 18% QoQ; 31 LDDs sold, installed base 161.
Net loss $(12.7)M ($(0.68)/share) vs net income $5.9M in Q3 2020; adjusted net loss $(12.2)M ($(0.65)/share).
Cash and investments $168.3M; long-term debt $39.6M as of Sep 30, 2021.
FY 2021 revenue guidance $21.0M-$21.4M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.